Fig. 3From: Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma modelH1-Vastatin caused angiogenesis inhibition in vivo and decreased microvessel density. a Immunostaining of CD34, a vessel endothelia marker, on brain tumour sections. The CD34+ cell numbers were fewer in the H1-Vastatin treated group than the PBS and H1-EGFP treated groups. b Histogram showing the microvessel density (MVD) in tumours of different treatment groups. Percentage of microvessel endothelial cells in the H1-Vastatin treated group was significant lower than in the PBS and H1-EGFP treated groups. (n = 3; * P < 0.05 against PBS treated group, # P < 0.05 against H1-EGFP treated group)Back to article page